Johnson & Johnson asks FDA for emergency use authorization of booster doseJohnson and Johnson is formally asking the FDA to authorize a booster for its COVID-19 vaccine.
FDA’s advisory panel recommends Pfizer booster for 65 and older, those at high riskDealing the White House a stinging setback, a government advisory panel overwhelmingly rejected a plan Friday to give Pfizer COVID-19 booster shots across the board, and ...
CDC issues warning against unvaccinated travel ahead of Labor Day weekend as delta variant surgesThe White House COVID-19 Response Team held a briefing on Tuesday (Aug. 31) and covered a wide range of topics.
Pfizer releases data that FDA will be relying on to make decision about granting an emergency use authorization
CDC advisory panel to determine guidelines for who should be vaccinated for COVID-19 first when a vaccine is available
